Stockscreener 앱 받기
353.68
0.67%
-2.40
시장 영업 전:
353.68
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Launches Synchrony™ Prefillable Syringe System for Biologics and Vaccines in Southeast Asia - BioPharma APAC
WST stock up nearly 33% YTD: Will the uptrend continue in the rest of 2026? - MSN
The Daikyo D2F Series PlungerWest Pharmaceutical focuses on high-barrier safety for prefilled syr - Ad-hoc-news.de
West Pharmaceutical Services (WST) Is Up 4.24% in One Week: What You Should Know - Yahoo Finance
Here's Why You Should Retain AMN Stock in Your Portfolio for Now - TradingView
West to Host Second-Quarter 2026 Conference Call - BioSpace
WST Maintains Rating by Evercore ISI Group -- Price Target Raises to $410 - GuruFocus
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors - MarketWatch
West Pharmaceutical updates strategy as global demand for drug delivery grows - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Looks Overvalued Despite Upcoming Q2 Earnings - Yahoo Finance
WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? L - The National Law Review
West Pharmaceutical Services Stock 10-Day Winning Spree: Stock Climbs 13% - Trefis
West Pharmaceutical rises on upbeat results, guidance raise - MSN
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - TradingView
West completes sale of on-body drug delivery device to AbbVie - Drug Delivery Business
West Pharmaceutical Services Stock Rockets 13% With 9-Day Winning Streak - Trefis
What to Expect From West Pharmaceutical Services' Q2 2026 Earnings Report - inkl
KeyBanc Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Raises Target Price to $390 - Moomoo
West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Growth on Drug Delivery Demand - Sahm
West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System - Sahm
KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical completes sale of SmartDose 3.5mL system By Investing.com - Investing.com Australia
Form 4 West Pharmaceutical Services Inc For: 1 July By Investing.com - Investing.com Canada
West Pharmaceutical (WST) director awarded new phantom stock units and RSUs - Stock Titan
West Pharmaceutical completes sale of SmartDose 3.5mL system - Investing.com
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services stock hits 52-week high at 363.38 USD - Investing.com
Westar™ RS LyoVials from West Pharmaceuticalmodular containment for complex injectables - AD HOC NEWS
West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Jump On Injectable DemandHas The Bull Case Changed? - Yahoo Finance
West Pharmaceutical Services, Inc.'s stock price skyrockets to $359.00, boasting a promising 1.22% increase - Smartkarma
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now - TradingView
WST Technical Analysis & Stock Price Forecast - Intellectia AI
The SmartDose Gen. II injector from West Pharmaceutical Services Inc.wearable biologics delivery - AD HOC NEWS
West Pharmaceutical Services Inc. stock rises Monday, still underperforms market - MarketWatch
West Pharmaceutical focuses on long term growth, shares steady in S&P 500 healthcare segment - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Analysis: Strong Revenue Growth and Bullish Analyst Ratings Offer Promising Prospects - DirectorsTalk Interviews
West Pharmaceutical Services Inc. (WST) Edges Higher as It Holds Above Key SupportBear Pennant - dars.gov.et
West Pharmaceutical Services earnings date approaches, shares backed by analyst interest - AD HOC NEWS
WST DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Class ActionWST - TMX Newsfile
Class Action Alert: Levi & Korsinsky Reminds West Pharmaceutical - The National Law Review
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical - The National Law Review
West Pharmaceutical Services names Michel Lagarde as next CEO, effective Aug. 31 - MSN
Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to - The National Law Review
Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) – Join by July 7, 2025Contact Levi & Korsinsky - The National Law Review
West Pharmaceutical steady on Friday, S&P 500 peer group shows mixed moves - AD HOC NEWS
Price to earnings forward of West Pharmaceutical Services, Inc. – NYSE:WST - TradingView
Is West Pharmaceutical stock outperforming the S&P 500? - MSN
Vest S&P 500 Dividend Aristocrats Target Income Fund's West Pharmaceutical Services Inc(WST) Holding History - GuruFocus
West Pharmaceutical adjusts guidance on GLP-1 demand, shares extend 30-day gain - AD HOC NEWS
Westar RS Lined Seal from West Pharmaceutical Services Inc.ready-for-use vial closure targets con - Ad-hoc-news.de
West Pharmaceutical Services, Inc. Actuals & Estimates (NYSE:WST) - TradingView
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
WST Forecast — Price Target — Prediction for 2027 - TradingView
West Pharmaceutical Services Inc (WST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
West Pharmaceutical Services stock hits 52-week high at $338.73 By Investing.com - Investing.com Nigeria
West Pharmaceutical Services stock hits 52-week high at $338.73 - Investing.com
West Pharmaceutical Services, Inc. (WST) hit a 52 week high, can the run continue? - MSN
6.33%
자본화:
|
볼륨(24시간):